Global PH & Rare Disease Lifecycle Marketing Lead

MSD; Rahway (NJ); Hybrid; USD 191,000 - 300,000; Full time

Benefits offered by this job

Annual bonus

Long-term incentive

Healthcare benefits

401(k)

Job summary

MSD seeks a Director of Life Cycle Management & Future Strategy for Pulmonary Hypertension and Rare Disease. Lead early commercialization development, partner with U.S.

and local market teams, and collaborate with Clinical, Medical Affairs, Market Access, and Digital Human Health. Responsibilities include developing global L3 Next strategies for indications like CpcPH-HFpEF, informing evidence needs, and defining commercial ambition for lifecycle expansion with key internal and external

Qualifications

• Bachelor's degree required; MBA preferred.
• Minimum 10 years of progressive marketing/sales/market access experience in pharma/biotech.
• Experience with lifecycle management and strategic brand planning is highly valued.

Responsibilities

• Develop global L3 Next strategies for potential indications (e.g., CpcPH-HFpEF).
• Represent commercial priorities on clinical sub-teams to inform evidence and value messaging.
• Define overarching commercial ambition and lifecycle expansion with cross-functional partners.
• Drive development of commercially informed product profiles, pricing, and access plans.
• Build deep disease-area knowledge to identify unmet needs and market opportunities.
• Lead commercial assessments of BD and lifecycle opportunities, including market potential.
• Manage budgets, agencies, and timelines to deliver projects on time and within budget.

Skills

Entrepreneurship

Strategic Planning

Change Catalyst

Innovation

Influence

Networking & Partnerships

Executional Excellence

Prior launches

Cross-functional collaboration

Education

Bachelor's Degree

MBA (Preferred)

Job description

MSD seeks a Director of Life Cycle Management & Future Strategy for Pulmonary Hypertension and Rare Disease. Lead early commercialization development, partner with U.S.

and local market teams, and collaborate with Clinical, Medical Affairs, Market Access, and Digital Human Health. Responsibilities include developing global L3 Next strategies for indications like CpcPH-HFpEF, informing evidence needs, and defining commercial ambition for lifecycle expansion with key internal and external